Fact Sheets: Public Views About Science
This roundup of findings shows public views about science-related issues and the role of science in French society. The findings come from a Pew Research Center survey conducted across 20 publics in Europe, the Asia-Pacific, Russia, the U.S., Canada and Brazil from October 2019 to March 2020.
Ratings of medical treatments, scientific achievements and STEM education in France
Majorities in most of the 20 publics surveyed saw their medical treatments in a favorable light on the eve of the global pandemic. Medical treatments were often seen more favorably than achievements in other areas.
Across the 20 publics, a median of 59% say their medical treatments are at least above average. In France, 58% think their country’s medical treatments are the best in the world or above average. Only about one-in-ten French think their medical treatments are below average (9%).
About four-in-ten in France view their scientific and technological achievements as above average or the best in the world (37% each). Roughly one-third of adults in France say their country’s university STEM education is the best in the world or above average (32%), while even fewer (20%) say this about their primary and secondary school STEM education.
Majorities in all publics agree that being a world leader in scientific achievement is at least somewhat important, but the share who view this as very important varies by public. A 20-public median of 51% place the highest level of importance on being a science world leader. In France, 47% of people say being a world leader in scientific achievements is very important.
Overall, there is broad agreement among these 20 publics that government investment in scientific research is worthwhile. A median of 82% say government investments in scientific research aimed at advancing knowledge are usually worthwhile for society over time. In France, 61% of people say this, the lowest share of any of the 20 publics surveyed.
Views on artificial intelligence, food science and childhood vaccines in France
Majorities in most publics see their government’s space exploration program as a good thing for society. Across the 20 publics, a median of 72% say their government’s space exploration program has mostly been a good thing for society. In France, some 64% say the European Space Agency’s space exploration program has been good for society.
Public views on artificial intelligence (AI) and using robots to automate jobs are more varied from public to public. A median of 53% say the development of AI, or computer systems designed to imitate human behaviors, has mostly been a good thing for society, while 33% say it has been a bad thing. The Center survey also finds that publics offer mixed views about the use of robots to automate jobs. Across the 20 publics, a median of 48% say such automation has mostly been a good thing, while 42% say it has been a bad thing.
In France, people tend to have more negative than positive views of both developments. Overall, 37% say artificial intelligence has been good for society, while 47% say it has been a bad thing.
Opinions about the effect of workplace automation through robotics are similar: 35% say it has been a good thing, compared with 49% who say it has been a bad thing.
Across most of the publics surveyed, views about the safety of fruits and vegetables grown with pesticides, food and drinks with artificial preservatives, and genetically modified foods tilt far more negative than positive. About half think produce grown with pesticides (median of 53%), foods made with artificial preservatives (53%) or genetically modified foods (48%) are unsafe. In France, people are similarly skeptical. Only 13% say fruits and vegetables grown with pesticides are safe, while a majority (59%) thinks they are unsafe and 27% say they don’t know about this issue to say. Similarly, 54% say genetically modified foods are unsafe to eat, and 53% say food and drinks with artificial preservatives are unsafe.
When it comes to childhood vaccines such as the measles, mumps and rubella (MMR) vaccine, a median of 61% say the preventive health benefits of such vaccines are high, and a median of 55% think there is no or only a low risk of side effects. France is among the survey publics least likely to rate the preventive health benefits as high and the risk of side effects as low or none. About half the French say the preventive health benefits from the MMR vaccine are high (52%); 44% rate the risk of side effects from the MMR vaccine as low or none.
Views on climate and the environment in France
Majorities across all 20 survey publics would prioritize protecting the environment, even if it causes slower economic growth. A median of 71% would prioritize environmental protection. In France, seven-in-ten think protecting the environment should be given priority, even if it causes slower economic growth and some loss of jobs. A far smaller share (23%) thinks creating jobs should be the top priority, even if the environment suffers to some extent.
Public concern about global climate change has gone up over the past few years in many publics surveyed by the Center.
Majorities in all 20 publics say they are seeing at least some effects of climate change where they live. A median of 70% say they are experiencing a great deal or some effects of climate change where they live. In France, six-in-ten say climate change is affecting where they live a great deal (36%) or some (24%).
A 20-public median of 58% say their national government is doing too little to reduce the effects of climate change. A majority in France (63%) say their government is doing too little to reduce the effects of climate change, while 26% say the government is doing about the right amount, and just 7% say it is doing too much.
Find out more
Read the full report online.
All surveys were conducted with nationally representative samples of adults ages 18 and older. Here is the survey methodology used in each public.